Executive Leadership

Dr. Frank Basile has over 20 years of executive leadership in the healthcare and medical industry. Prior to joining Aegis Sciences Corporation, Dr. Basile served as President and Chief Executive Officer at Miraca Life Sciences, Inc. and brings extensive experience from his training as a physician, a strategy consultant, and a healthcare executive.

Dr. Basile earned his Bachelor of Medicine and Bachelor of Surgery from University of Melbourne in Melbourne, Australia and a Master of Business Administration from the Melbourne Business School.

As Chief Legal Officer, Joel Galanter manages all of Aegis’ legal and regulatory operations. Before joining Aegis in 2013, Galanter was a partner in the litigation group at Adams and Reese LLP where he served a diverse group of clients across the country in cases before federal and state courts and regulatory agencies.

Galanter is a graduate of Vanderbilt University Law School.

Dr. Hardison is the laboratory director for the BioPharma laboratory. Prior to joining Aegis Sciences Corporation in 2015, he was the founding laboratory director of Assurance Scientific Laboratories in Birmingham, AL.

Dr. Hardison received his Bachelor of Science from Lipscomb University in Nashville, TN, and his Doctorate of Philosophy in molecular physiology and biophysics from the University of Alabama Birmingham (UAB) in Birmingham, AL. Following a post-doctoral fellowship at UAB, Dr. Hardison completed a fellowship in Clinical Molecular Genetics at Baylor College of Medicine in Houston, TX.

Dr. Hardison is a member of the American College of Medical Genetics and the American Society for Mass Spectrometry. He has published numerous peer reviewed publications, book chapters, and presented at several scientific meetings in the fields of immunology, toxicology, and genetics.

Dr. Heltsley conducts research in measurement science to enable Aegis to respond to the emerging needs in the forensic drug testing arena. She is responsible for the development, implementation and assessment of new technologies. Prior to joining Aegis Sciences Corporation in 2007, Dr. Heltsley completed a National Research Council postdoctoral fellowship and served as a Research Chemist at the National Institute of Standards and Technology in Charleston, SC.

Dr. Heltsley earned her bachelor’s degree in chemistry, environmental science, and biology and master’s degree in chemistry from Western Kentucky University in Bowling Green, KY. Following completion of her Master of Science, she received her Ph.D. in environmental toxicology from North Carolina State University in Raleigh, NC. She is a member of the American Chemical Society.